» Articles » PMID: 16817503

[Morphological Aspects of Atherosclerosis Lesion: Past and Present]

Overview
Journal Clin Ter
Specialty Pharmacology
Date 2006 Jul 5
PMID 16817503
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis is an inflammatory process disease that involves the artery wall and that is characterized by the progressive accumulation of lipids. The term arteriosclerosis has been created by Lobstein in 1833. Subsequently, during the 19th century, the contribution of Rokitansky and Virchow was important to elucidate the pathogenesis of arteriosclerosis and the morphologic aspects of the plaque. In the beginning of the 20th century, Aschoff was a leading proponent who regarded the morphologically different intimal lipid deposits of children and adults as early and late stages of one disease and he called them atherosis and atherosclerosis, respectively. The first classification of atherosclerosis was made by the World Health Organization (WHO) in 1958 and it consisted of the following sequence: fatty streak, atheroma, fibrous plaque and complicated lesions. In 1990s, thanks to much more sensitive techniques, the American Heart Association (AHA) proposed a new morphological classification based on eight lesion types designated by Roman numerals which indicate the usual sequence of lesion progression. Finally, Virmani et al. (2000) described a classification with the add of a specific plaque type, not recognized by the AHA classification, called "thin fibrous cap atheroma" which is more likely to rupture. The atherosclerotic process is characterized by typical ultrastructural changes that mainly involve the endothelial and smooth muscle cells. The morphological alterations of the endothelium are associated with dysfunctions leading to a proinflammatory and prothrombotic phenotype. This process seems to be due to turbulent blood flow and low fluid shear stress that normally occurs in particular regions of the vascular tree. Inflammation has a key role in the pathogenesis of atherosclerosis and it is supported by numerous factors such as modified LDL, hypertension, diabetes mellitus, free radicals and, in particular, by infectious agents such as Chlamydia pneumoniae.

Citing Articles

Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice.

Madaudo C, Coppola G, Parlati A, Corrado E Int J Mol Sci. 2024; 25(11).

PMID: 38892201 PMC: 11173271. DOI: 10.3390/ijms25116016.


infection increases the risk of carotid plaque formation: Clinical samples combined with bioinformatics analysis.

Chen Y, You N, Yang C, Zhang J Heliyon. 2023; 9(9):e20037.

PMID: 37809782 PMC: 10559771. DOI: 10.1016/j.heliyon.2023.e20037.


A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern.

Zhang Z, Zheng M, Lei H, Jiang Z, Chen Y, He H Sci Rep. 2023; 13(1):7224.

PMID: 37142746 PMC: 10160090. DOI: 10.1038/s41598-023-34462-8.


Relationship between non-alcoholic fatty liver disease and coronary heart disease.

Arslan U, Yenercag M World J Clin Cases. 2020; 8(20):4688-4699.

PMID: 33195636 PMC: 7642538. DOI: 10.12998/wjcc.v8.i20.4688.


Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque.

Yu L, Hu K, Liu C, Hung C, Bair M, Chen M Medicine (Baltimore). 2019; 98(9):e14672.

PMID: 30817593 PMC: 6831312. DOI: 10.1097/MD.0000000000014672.